Gossamer Bio, Inc. (GOSS)
10.63
-0.76
(-6.69%)
USD |
NASDAQ |
Sep 11, 16:00
10.65
+0.02
(+0.19%)
After-Hours: 17:27
Gossamer Bio Gross Profit (TTM) : 52.36M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 52.36M |
| March 31, 2026 | 54.64M |
| December 31, 2025 | 47.47M |
| September 30, 2025 | 42.20M |
| June 30, 2025 | 37.52M |
| March 31, 2025 | 121.10M |
| December 31, 2024 | 110.57M |
| September 30, 2024 | 101.26M |
| June 30, 2024 | 91.76M |
| March 31, 2024 | -4.244M |
| December 31, 2023 | -4.398M |
| September 30, 2023 | -4.515M |
| June 30, 2023 | -4.524M |
| March 31, 2023 | -4.472M |
| December 31, 2022 | -4.429M |
| September 30, 2022 | -4.588M |
| June 30, 2022 | -4.792M |
| March 31, 2022 | -4.99M |
| Date | Value |
|---|---|
| December 31, 2021 | -5.167M |
| September 30, 2021 | -5.094M |
| June 30, 2021 | -4.957M |
| March 31, 2021 | -4.647M |
| December 31, 2020 | -4.268M |
| September 30, 2020 | -5.523M |
| June 30, 2020 | -4.597M |
| March 31, 2020 | -3.815M |
| December 31, 2019 | -3.089M |
| September 30, 2019 | -0.759M |
| June 30, 2019 | -0.633M |
| March 31, 2019 | -0.46M |
| December 31, 2018 | -0.297M |
| September 30, 2018 | -0.163M |
| June 30, 2018 | -0.038M |
| March 31, 2018 | -0.006M |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| United Therapeutics Corp. | 2.717B |
| Arbutus Biopharma Corp. | 181.68M |
| Kura Oncology, Inc. | 75.37M |
| ACADIA Pharmaceuticals, Inc. | 1.038B |
| Alnylam Pharmaceuticals, Inc. | 3.827B |